Pampa Energia SA(PAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PAM Pampa Energia SA

Trading 04-07 12:26:16 EDT

88.02

-0.46

-0.52%

High89.47	Low87.43	Vol89.29K
Open88.99	D1 Closing88.48	Amplitude2.31%
Mkt Cap4.80B	Tradable Cap2.38B	Total Shares54.54M
T/O7.90M	T/O Rate0.33%	Tradable Shares27.04M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PAM","market":"US","secType":"STK","nameCN":"Pampa Energia SA","latestPrice":88.02,"timestamp":1775579171843,"preClose":88.48,"halted":0,"volume":89293,"delay":0,"changeRate":-0.005198915009041681,"floatShares":27042273,"shares":54540800,"eps":6.930125,"marketStatus":"Trading","change":-0.46,"latestTime":"04-07 12:26:16 EDT","open":88.99,"high":89.47,"low":87.43,"amount":7902615.336510001,"amplitude":0.023056,"askPrice":88.61,"askSize":100,"bidPrice":87.85,"bidSize":1,"shortable":3,"etf":0,"ttmEps":6.930125,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1775592000000},"marketStatusCode":2,"adr":1,"adrRate":25,"listingDate":1162789200000,"exchange":"NYSE","adjPreClose":88.48,"preHourTrading":{"tag":"盘前","latestPrice":86.6812,"preClose":88.48,"latestTime":"06:31 EDT","volume":1,"amount":86.6812,"timestamp":1775557880807,"change":-1.7988,"changeRate":-0.02033,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":88,"preClose":88.48,"latestTime":"18:25 EDT","volume":458,"amount":40426.3724,"timestamp":1775514334854,"change":-0.48,"changeRate":-0.005425,"amplitude":0.005425},"volumeRatio":0.585909,"impliedVol":0.4383,"impliedVolPercentile":0.292},"requestUrl":"/m/hq/s/PAM","defaultTab":"news","newsList":[{"id":"2623303610","title":"Optima Health Launches £35m Underwritten Open Offer to Fund PAM Deal and Boost Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2623303610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623303610?lang=en_us&edition=fundamental","pubTime":"2026-03-31 14:11","pubTimestamp":1774937488,"startTime":"0","endTime":"0","summary":"Optima Health PLC ( ($GB:OPT) ) has issued an update. Optima Health plc has launched an underwritten open offer to raise approximately £35m through...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-launches-35m-underwritten-open-offer-to-fund-pam-deal-and-boost-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-launches-35m-underwritten-open-offer-to-fund-pam-deal-and-boost-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PAM","BK4563","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623731901","title":"Press Release: Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623731901","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623731901?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:53","pubTimestamp":1774867980,"startTime":"0","endTime":"0","summary":"New data for NMRA-511 supports unsurpassed clinical effect in a pre-specified population comparable to Rexulti and Auvelity pivotal studies. KOASTAL-2 and -3 fully enrolled in the first quarter of 2026; on track for topline readout in the second quarter of 2026. NMRA-898 selected as lead program in M4 franchise based on promising clinical results from ongoing Phase 1 study. \"We saw significant progress in 2025, laying the foundation for a catalyst-rich year ahead as we advance our pipeline of next-generation therapies for people living with brain diseases,\" said Paul L. Berns, co-founder, chairman and chief executive officer of Neumora. \"In the first quarter of 2026, we confirmed next steps for navacaprant and our M4 franchise, as well as generated compelling results supporting the potential unsurpassed profile of NMRA-511 in Alzheimer's disease agitation, which we built upon today with the announcement of additional data from a pre-specified analysis.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","AD","NMRA","PAM","BK4081","BK4132","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622094387","title":"Optima Health clears Irish FDI hurdle for £100m PAM acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2622094387","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622094387?lang=en_us&edition=fundamental","pubTime":"2026-03-25 00:42","pubTimestamp":1774370547,"startTime":"0","endTime":"0","summary":"Optima Health PLC ( ($GB:OPT) ) has shared an update. Optima Health has secured Irish foreign direct investment clearance for its approximately £10...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-clears-irish-fdi-hurdle-for-100m-pam-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-clears-irish-fdi-hurdle-for-100m-pam-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","PAM","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621720411","title":"Optima Health Plans CFO Transition Ahead of PAM Healthcare Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2621720411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621720411?lang=en_us&edition=fundamental","pubTime":"2026-03-23 15:15","pubTimestamp":1774250152,"startTime":"0","endTime":"0","summary":"Optima Health PLC ( ($GB:OPT) ) just unveiled an update. Optima Health plc, the UK’s leading provider of technology-enabled corporate health and we...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/optima-health-plans-cfo-transition-ahead-of-pam-healthcare-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/optima-health-plans-cfo-transition-ahead-of-pam-healthcare-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4081","BK4585","LU0128526141.USD","BK4588","BK4563","BK4581","XBI","HCSG","BK4137","LU0029874061.USD","LABU","PAM","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618900205","title":"Pampa Energia Sa : HSBC Raises to Buy From Hold; Raises Target Price to $97 From $88","url":"https://stock-news.laohu8.com/highlight/detail?id=2618900205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618900205?lang=en_us&edition=fundamental","pubTime":"2026-03-12 14:22","pubTimestamp":1773296551,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4081","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618244947","title":"MACOM to Showcase Innovative Connectivity Solutions at OFC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618244947","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618244947?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:45","pubTimestamp":1773233100,"startTime":"0","endTime":"0","summary":"LOWELL, Mass., March  11, 2026 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, will participate in OFC 2026, taking place March 17–19, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253780/19814/en/MACOM-to-Showcase-Innovative-Connectivity-Solutions-at-OFC-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","LU0054578231.USD","SI","CW","BK4563","BK4187","BK4081","BK4082","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618930858","title":"Press Release: Lipocine Announces Financial Results for the Full Year Ended December 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930858","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930858?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:00","pubTimestamp":1773144000,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, March 10, 2026 /PRNewswire/ -- Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the full year ended December 31, 2025 and provided a corporate update.\"We believe 2025 was a pivotal year for Lipocine as we continue to advance our pipeline and expand our market presence. The progress we've made, especially with our postpartum depression therapeutic, LPCN 1154, demonstrates the strength of our science and our team's commitment to delivering more effective treatments for patients in need,\" said Dr Mahesh Patel, Lipocine President and CEO. \"We're excited about the near-term milestones ahead and remain committed to advancing our pipeline proficiently.\". -- Lipocine is developing LPCN 1154, a rapid onset, short treatment duration. oral product candidate comprising the neuroactive steroid brexanolone for. -- The last patient completed the fina","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","IE00B19Z3B42.SGD","BK4585","IE00B19Z3581.USD","BK4588","BK4218","ASM","DRE","BK4081","PAM","PK","BK4105","BK4563","03160","BK4181","AES","BK4188","BK4519","IE00B7SZLL34.SGD","LU1093756168.USD","BK4561","TM","BK4530","BK4121","BK4555","LU0061475181.USD","PPD","GCC","BK4099","LPCN","BK4007","LU1093756325.SGD","BK4171","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618670342","title":"Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2618670342","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618670342?lang=en_us&edition=fundamental","pubTime":"2026-03-10 05:42","pubTimestamp":1773092520,"startTime":"0","endTime":"0","summary":"As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3252366/0/en/Celcuity-Announces-Publication-of-Results-from-PIK3CA-Wild-Type-Cohort-of-Phase-3-VIKTORIA-1-Study-of-Gedatolisib-Regimens-in-HR-HER2-Advanced-Breast-Cancer-in-Journal-of-Clinical-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEIS","IE00BHPRN162.USD","WT","MT","IE00B7SZL793.SGD","LU1815336091.USD","BK4157","BK4225","LU0757428866.USD","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4561","IE0031619046.USD","BK4203","HR","BK4135","BK4006","PAM","BK4081","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616536963","title":"Earnings Flash (PAM) Pampa Energia Posts Q4 Earnings of $3 per ADS","url":"https://stock-news.laohu8.com/highlight/detail?id=2616536963","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616536963?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:19","pubTimestamp":1772486379,"startTime":"0","endTime":"0","summary":"Earnings Flash (PAM) Pampa Energia Posts Q4 Earnings of $3 per ADS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616366126","title":"Pampa Energia Q4 EPS $3.00 Beats $1.05 Estimate, Sales $507.000M Miss $407.778B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366126","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616366126?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:04","pubTimestamp":1772485457,"startTime":"0","endTime":"0","summary":"Pampa Energia (NYSE:PAM) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $1.05 by 185.71 percent. This is a 57.89 percent increase over earnings of $1.90 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/50983190/pampa-energia-q4-eps-3-00-beats-1-05-estimate-sales-507-000m-miss-407-778b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pampa Energia Q4 EPS $3.00 Beats $1.05 Estimate, Sales $507.000M Miss $407.778B Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","PAM","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616657803","title":"Pampa Energia S.A. trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2616657803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616657803?lang=en_us&edition=fundamental","pubTime":"2026-03-03 04:30","pubTimestamp":1772483411,"startTime":"0","endTime":"0","summary":"15:26 EST Pampa Energia (PAM) S.A. trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pampa-energia-s-a-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pampa-energia-s-a-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPENF","BK4563","PAM","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616365138","title":"Nyse Halt Pampa Energia Sa  News Pending Lst $78.480000","url":"https://stock-news.laohu8.com/highlight/detail?id=2616365138","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616365138?lang=en_us&edition=fundamental","pubTime":"2026-03-03 04:26","pubTimestamp":1772483216,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nAQN2LOH0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4081","BK4563","PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614690698","title":"Pampa Energia SA  expected to post earnings of $1.04 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2614690698","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614690698?lang=en_us&edition=fundamental","pubTime":"2026-02-28 03:02","pubTimestamp":1772218939,"startTime":"0","endTime":"0","summary":"Pampa Energia SA  expected to post earnings of $1.04 a share - Earnings Preview Pampa Energia SA PAM.N, PAM is expected to  show a rise in quarterly revenue when it reports  results on March 2 for the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL8N3ZN2IY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","PAM","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613781524","title":"Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781524","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613781524?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:00","pubTimestamp":1771848000,"startTime":"0","endTime":"0","summary":"Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growthAUVELITY 4Q and full year 2025 net product sales of $15","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3242481/33090/en/Axsome-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4505","AXSM","BK4135","PAM","BK4585","CNS","BK4132","ADHD","BK4007","BK4081","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111206864","title":"Earning Preview: Pampa Energia SA this quarter’s revenue is expected to increase by 24.46%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1111206864","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111206864?lang=en_us&edition=fundamental","pubTime":"2026-02-23 11:33","pubTimestamp":1771817613,"startTime":"0","endTime":"0","summary":"Title Earning Preview: Pampa Energia SA this quarter’s revenue is expected to increase by 24.46%, and institutional views are bullish Abstract Pampa Energia SA is scheduled to report on March 2, 2026...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Pampa Energia SA this quarter’s revenue is expected to increase by 24.46%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605211095","title":"Bragg Gaming Launches Cost-Cutting Restructure and Extends Entain PAM Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2605211095","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605211095?lang=en_us&edition=fundamental","pubTime":"2026-01-21 00:57","pubTimestamp":1768928261,"startTime":"0","endTime":"0","summary":"Bragg Gaming Group Inc ( ($TSE:BRAG) ) just unveiled an update. In a material change report dated January 16, 2026, Bragg Gaming Group detailed a s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bragg-gaming-launches-cost-cutting-restructure-and-extends-entain-pam-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bragg-gaming-launches-cost-cutting-restructure-and-extends-entain-pam-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PAM","BK4563","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601883066","title":"Press Release: Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2601883066","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601883066?lang=en_us&edition=fundamental","pubTime":"2026-01-05 19:35","pubTimestamp":1767612900,"startTime":"0","endTime":"0","summary":"Multiple clinical data readouts expected in 2026 present opportunity for substantial value creation. KOASTAL-2 and -3 on track for consolidated topline readout in the second quarter of 2026. Plans to conduct NMRA-215 clinical program in 2026 following class-leading preclinical data from diet induced obesity model. NMRA-215: Plans to initiate Phase 1 clinical program following class-leading preclinical data. Neumora expects to initiate a clinical program evaluating NMRA-215 monotherapy and combination therapy for the treatment of obesity in the first half of 2026. The Company expects to report weight loss data following treatment wit","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4007","BK4081","BK4132","NMRA","PAM","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595792540","title":"XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab","url":"https://stock-news.laohu8.com/highlight/detail?id=2595792540","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595792540?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:30","pubTimestamp":1767097800,"startTime":"0","endTime":"0","summary":"– Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine d","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/30/3211329/7281/en/XOMA-Royalty-and-Takeda-Execute-Strategic-Royalty-Sharing-Transaction-and-Amend-Existing-Agreement-for-Mezagitamab.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBC","PAM","BK4081","PSC","BK4563","IBAT","BK4139","XOMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590343426","title":"Press Release: Saviynt Raises $700M at Approximately $3B Valuation in KKR-Led Round to Establish Identity Security as the Foundation for the AI Era","url":"https://stock-news.laohu8.com/highlight/detail?id=2590343426","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590343426?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:00","pubTimestamp":1765281600,"startTime":"0","endTime":"0","summary":"KKR joined by Sixth Street Growth, TenEleven, and Carrick Capital as Principal Investors. LOS ANGELES and NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Saviynt, a leading identity security company, today announced a $700M Series B Growth Equity Financing at a valuation of approximately $3 billion. Funds managed by KKR, a leading global investment firm, led the round with participation from Sixth Street Growth and TenEleven, as well as new funding from existing Series A investor Carrick Capital Partners. The multi-firm investment underscores a shared conviction that identity management is the foundational infrastructure for organizations deploying AI at scale.\"This is a defining moment for Saviynt and the industry,\" said Sachin Nayyar, Founder & CEO of Saviynt. \"The demand for secure, governed identity has never been greater, and this growth investment gives us the resources to meet it head-on. We chose to strategically partner with KKR and Sixth Street Growth because they understand how centr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU1935042215.USD","IE00B3QW5Z07.USD","BK4528","LU0106831901.USD","LU1791807156.HKD","BK4023","BK4543","IGA","LU1201861249.SGD","LU0314104364.USD","LU1935042991.SGD","LU1935043023.USD","LU1668664300.SGD","LU0130102774.USD","LU0648001328.SGD","BK4563","BK4588","BK4135","BK4585","BK4587","LU1935043536.SGD","LU1935042488.USD","AI","PAM","BK4551","BK4081","IE00BGHQF748.EUR","KKR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586260275","title":"Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260275","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260275?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:05","pubTimestamp":1764191100,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Nov.  26, 2025  (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that an a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195381/0/en/Celcuity-to-Present-Updated-Data-from-the-PIK3CA-Wild-Type-Cohort-of-the-Phase-3-VIKTORIA-1-Trial-at-the-2025-San-Antonio-Breast-Cancer-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4563","PAM","BK4135","IE00BHPRN162.USD","WT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pampaenergia.com","stockEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.1209},{"period":"3month","weight":0.0507},{"period":"6month","weight":0.4493},{"period":"1year","weight":0.2902},{"period":"ytd","weight":-0.0003}],"compareEarnings":[{"period":"1week","weight":0.0427},{"period":"1month","weight":-0.02},{"period":"3month","weight":-0.0475},{"period":"6month","weight":-0.0211},{"period":"1year","weight":0.3041},{"period":"ytd","weight":-0.0337}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pampa Energía S.A. operates as an integrated power company in Argentina. The company operates through Electricity Generation, Oil and Gas, Petrochemicals, and Holding and Other Business segments. It generates electricity through thermal plants, hydroelectric plants, and wind farms with a 5,332 megawatt (MW) installed capacity. The company also explores for and produces oil and gas in the provinces of Neuquén and Río Negro. In addition, it produces petrochemicals, such as styrene, synthetic rubber, and polystyrene. Further, the company operates and maintains a 22,391 km high-voltage electricity transmission network in Argentina. Additionally, it holds a concession for the transportation of natural gas with 9,248 km of gas pipelines in the center, west, and south of Argentina; and processes and sells natural gas liquids in Bahía Blanca in the Province of Buenos Aires, as well as offers related advisory services. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energía S.A. in September 2008. Pampa Energía S.A. was incorporated in 1945 and is based in Buenos Aires, Argentina.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.026743},{"month":2,"riseRate":0.235294,"avgChangeRate":-0.035603},{"month":3,"riseRate":0.588235,"avgChangeRate":0.043228},{"month":4,"riseRate":0.294118,"avgChangeRate":-0.040827},{"month":5,"riseRate":0.625,"avgChangeRate":0.026165},{"month":6,"riseRate":0.375,"avgChangeRate":0.002742},{"month":7,"riseRate":0.625,"avgChangeRate":0.033422},{"month":8,"riseRate":0.5,"avgChangeRate":-0.035441},{"month":9,"riseRate":0.5,"avgChangeRate":0.048997},{"month":10,"riseRate":0.8125,"avgChangeRate":0.115042},{"month":11,"riseRate":0.588235,"avgChangeRate":0.056056},{"month":12,"riseRate":0.470588,"avgChangeRate":0.016592}],"exchange":"NYSE","name":"Pampa Energia SA","nameEN":"Pampa Energia SA","securityTypeName":"DR","adrRate":"1:25"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pampa Energia SA(PAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pampa Energia SA(PAM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pampa Energia SA,PAM,Pampa Energia SA股票,Pampa Energia SA股票老虎,Pampa Energia SA股票老虎国际,Pampa Energia SA行情,Pampa Energia SA股票行情,Pampa Energia SA股价,Pampa Energia SA股市,Pampa Energia SA股票价格,Pampa Energia SA股票交易,Pampa Energia SA股票购买,Pampa Energia SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pampa Energia SA(PAM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pampa Energia SA(PAM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction